Literature DB >> 3755255

Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study.

D P Levine, L R Crane, M J Zervos.   

Abstract

For one year all narcotic addicts admitted to the Detroit Medical Center with infectious endocarditis (74 cases) were compared with a control group of bacteremic addicts who had other infections (106 cases). Endocarditis was caused by Staphylococcus aureus (60.8% of cases), streptococci (16.2%), Pseudomonas aeruginosa (13.5%), mixed bacteria (8.1%), and Corynebacterium JK (1.4%). S. aureus endocarditis most frequently involved the tricuspid valve; streptococci infected left-sided valves significantly more often than other organisms (P = .001). Biventricular and multiple-valve infections were commonest in patients with pseudomonas endocarditis (P = .05). Two-dimensional echocardiography, when combined with an abnormal chest roentgenogram, was highly predictive of endocarditis. Bacteremia in the absence of endocarditis was associated with primary skin and soft tissue infection, mycotic aneurysm at the site of narcotic injection, septic arthritis, septic thrombophlebitis, pneumonia, osteomyelitis, mediastinal abscess, and unclassified infection. Polymicrobial bacteremia in the nonendocarditis group was associated with markedly increased morbidity. Mild hyponatremia occurred in 41% of all patients and was also associated with significantly increased morbidity. Analysis of the two groups disclosed similarities and differences with implications for the pathophysiology and treatment of addicts with bacteremic infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3755255     DOI: 10.1093/clinids/8.3.374

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  31 in total

Review 1.  Medical complications of intravenous drug use.

Authors:  M D Stein
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

2.  Abbreviated therapy for right-sided Staphylococcus aureus endocarditis in injecting drug users: the time has come?

Authors:  M J DiNubile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

Review 3.  Acute infective endocarditis.

Authors:  Jay R McDonald
Journal:  Infect Dis Clin North Am       Date:  2009-09       Impact factor: 5.982

Review 4.  Phagocytosis and oxycytosis: two arms of human innate immunity.

Authors:  Hayk Minasyan
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

Review 5.  Infective endocarditis in intravenous drug abusers: an update.

Authors:  C Sousa; C Botelho; D Rodrigues; J Azeredo; R Oliveira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-20       Impact factor: 3.267

Review 6.  Corynebacterium jeikeium endocarditis: a systematic overview spanning four decades.

Authors:  F Mookadam; M Cikes; L M Baddour; I M Tleyjeh; M Mookadam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

7.  Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cádiz.

Authors:  M Torres-Tortosa; M de Cueto; A Vergara; A Sánchez-Porto; E Pérez-Guzmán; M González-Serrano; J Canueto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

Review 8.  Polymicrobial endocarditis involving Veillonella parvula in an intravenous drug user: case report and literature review of Veillonella endocarditis.

Authors:  M A Pérez-Jacoiste Asín; M Fernández-Ruiz; I Serrano-Navarro; S Prieto-Rodriguez; J M Aguado
Journal:  Infection       Date:  2013-03-01       Impact factor: 3.553

9.  Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Pamela A Moise; George Sakoulas; Alan Forrest; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

10.  Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  S L Davis; M B Perri; S M Donabedian; C Manierski; A Singh; D Vager; N Z Haque; K Speirs; R R Muder; B Robinson-Dunn; M K Hayden; M J Zervos
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.